Preliminary Agenda Now Available

Couples experiencing infertility or failed pregnancy can now take advantage of a number of molecular diagnostic options to determine the health and wellness of their embryos as well as their own fertility. Cambridge Healthtech Institute’s Second Annual Reproductive Genetic Diagnostics conference examines the latest in preimplantation diagnostic and screening technologies, including their applications in assessing mtDNA load; determining aneuploidy through single-gene disorders; and assessing mosaicism. The meeting will also examine the potential for non-invasive PGD by blastocentesis, being developed in response to the potential effect biopsy and vitrification may have on the development of the embryo. There will be discussion on PGD for donor eggs, such as how much or how often testing should be done. The meeting will also cover advances in CRISPR, including current research and capabilities, as well as how this technology may or may not be used in the future. New this year, special attention will be paid to molecular diagnostics for finding infertility biomarkers in sperm and the uterus.

Preliminary Agenda


ADVANCES AND PRACTICAL APPLICATIONS IN PGD AND PGS

Understanding Mosaicism: DNA Methylation Dynamics of the Human Preimplantation Embryo

Alexander Meissner, Ph.D., Professor, Stem Cell & Regenerative Biology, Harvard University

Novel Application of NGS at NLRP7 to Permit Single Embryo Transfer for Patient with Multiple Consecutive Gestational Trophoblastic Disease (Molar Pregnancy)

E. Scott Sills, M.D., Ph.D., Medical Director, Reproductive Research Office, Center for Advanced Genetics

Developments in Comprehensive Chromosome Screening

Nathan R. Treff, Ph.D., Director, Molecular Biology Research, Reproductive Medicine Associates of New Jersey


PROSPECTS FOR LESS- AND NON-INVASIVE DIAGNOSTICS

The Potential Use of Blastocoel Fluid from Differentiated Blastocysts to Conduct Preimplantation Genetic Screening

Kyle Tobler, M.D., Assistant Professor, Faculty, Reproductive Endocrinology and Infertility, Obstetrics and Gynecology, Womack Army Medical Center, Fort Bragg North Carolina

Corona Cell RNA Sequencing from Individual Oocytes Revealed Transcripts and Pathways Linked to Euploid Oocyte Competence and Live Birth

Mandy Katz-Jaffe, Ph.D., Scientific Director, National Foundation for Fertility Research, Colorado Center for Reproductive Medicine

Non-Invasive Testing of Gametes and Embryos for IVF

Denny Sakkas, Ph.D., Scientific Director, Boston IVF


BEYOND PGD: CARRIER SCREENING AND POC TESTING

Spectrum of Cytogenomic Abnormalities Revealed by Array-CGH in Products of Conception Culture Failure and Normal Karyotype Samples

Peining Li, Ph.D., Associate Professor, Genetics, Yale School of Medicine


MOLECULAR DIAGNOSTICS FOR INFERTILITY AND IMPLANTATION FAILURE

Decoding the Genetic Basis of Human Fertility Potential and Infertility Conditions

Piraye Yurttas Beim, Ph.D., Founder, CEO, Celmatix

Sperm RNAs: Biomarkers of Male Fitness and the Birth of a Healthy Child

Stephen A. Krawetz, B.Sc., Ph.D., Associate Director C.S. Mott Center for Human Growth and Development, Charlotte B. Failing Professor of Fetal Therapy and Diagnosis, Ob/Gyn & Molecular Medicine & Genetics, Wayne State University School of Medicine

Mitochondrial DNA as a Biomarker for in vitro Fertilization Outcome

Emre Seli, MD, Professor, Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine




For more details on the conference, please contact:
Kaitlin Searfoss
Conference Producer
Cambridge Healthtech Institute
Phone: (+1) 781-972-5498
Email: ksearfoss@healthtech.com

For partnering and sponsorship information, please contact:
Ilana Quigley
Senior Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-5457
Email: iquigley@healthtech.com


Who should attend:

  • Reproductive Endocrinologists
  • Embryologists
  • Cytogeneticists
  • Fertility Specialists
 
  • Maternal/Fetal Medicine
  • OB-GYN Physicians
  • Genetic Counselors
  • Andrologists